author_facet Bruni, L
Tagliapietra, G
Innocenti, P
Bruni, L
Tagliapietra, G
Innocenti, P
author Bruni, L
Tagliapietra, G
Innocenti, P
spellingShingle Bruni, L
Tagliapietra, G
Innocenti, P
Journal of International Medical Research
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
Biochemistry (medical)
Cell Biology
Biochemistry
General Medicine
author_sort bruni, l
spelling Bruni, L Tagliapietra, G Innocenti, P 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058401200406 <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p &lt; 0·05), vesicles, crusts and burning sensation (p &lt; 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p &lt; 0·01 for pain; p &lt; 0·05 for erythema) more than neuramide. </jats:p> Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide Journal of International Medical Research
doi_str_mv 10.1177/030006058401200406
facet_avail Online
finc_class_facet Chemie und Pharmazie
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint SAGE Publications, 1984
imprint_str_mv SAGE Publications, 1984
issn 0300-0605
1473-2300
issn_str_mv 0300-0605
1473-2300
language English
mega_collection SAGE Publications (CrossRef)
match_str bruni1984herpeszostertreatmentsresultsofaclinicaltrialrelativetotheuseofrifamycinsvversusneuramide
publishDateSort 1984
publisher SAGE Publications
recordtype ai
record_format ai
series Journal of International Medical Research
source_id 49
title Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_unstemmed Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_full Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_fullStr Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_full_unstemmed Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_short Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_sort herpes zoster treatments: results of a clinical trial relative to the use of rifamycin sv versus neuramide
topic Biochemistry (medical)
Cell Biology
Biochemistry
General Medicine
url http://dx.doi.org/10.1177/030006058401200406
publishDate 1984
physical 255-260
description <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p &lt; 0·05), vesicles, crusts and burning sensation (p &lt; 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p &lt; 0·01 for pain; p &lt; 0·05 for erythema) more than neuramide. </jats:p>
container_issue 4
container_start_page 255
container_title Journal of International Medical Research
container_volume 12
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792325571010625542
geogr_code not assigned
last_indexed 2024-03-01T12:07:42.714Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Herpes+Zoster+Treatments%3A+Results+of+a+Clinical+Trial+Relative+to+the+Use+of+Rifamycin+SV+versus+Neuramide&rft.date=1984-07-01&genre=article&issn=1473-2300&volume=12&issue=4&spage=255&epage=260&pages=255-260&jtitle=Journal+of+International+Medical+Research&atitle=Herpes+Zoster+Treatments%3A+Results+of+a+Clinical+Trial+Relative+to+the+Use+of+Rifamycin+SV+versus+Neuramide&aulast=Innocenti&aufirst=P&rft_id=info%3Adoi%2F10.1177%2F030006058401200406&rft.language%5B0%5D=eng
SOLR
_version_ 1792325571010625542
author Bruni, L, Tagliapietra, G, Innocenti, P
author_facet Bruni, L, Tagliapietra, G, Innocenti, P, Bruni, L, Tagliapietra, G, Innocenti, P
author_sort bruni, l
container_issue 4
container_start_page 255
container_title Journal of International Medical Research
container_volume 12
description <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p &lt; 0·05), vesicles, crusts and burning sensation (p &lt; 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p &lt; 0·01 for pain; p &lt; 0·05 for erythema) more than neuramide. </jats:p>
doi_str_mv 10.1177/030006058401200406
facet_avail Online
finc_class_facet Chemie und Pharmazie, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY
imprint SAGE Publications, 1984
imprint_str_mv SAGE Publications, 1984
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 0300-0605, 1473-2300
issn_str_mv 0300-0605, 1473-2300
language English
last_indexed 2024-03-01T12:07:42.714Z
match_str bruni1984herpeszostertreatmentsresultsofaclinicaltrialrelativetotheuseofrifamycinsvversusneuramide
mega_collection SAGE Publications (CrossRef)
physical 255-260
publishDate 1984
publishDateSort 1984
publisher SAGE Publications
record_format ai
recordtype ai
series Journal of International Medical Research
source_id 49
spelling Bruni, L Tagliapietra, G Innocenti, P 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058401200406 <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p &lt; 0·05), vesicles, crusts and burning sensation (p &lt; 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p &lt; 0·01 for pain; p &lt; 0·05 for erythema) more than neuramide. </jats:p> Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide Journal of International Medical Research
spellingShingle Bruni, L, Tagliapietra, G, Innocenti, P, Journal of International Medical Research, Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide, Biochemistry (medical), Cell Biology, Biochemistry, General Medicine
title Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_full Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_fullStr Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_full_unstemmed Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_short Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
title_sort herpes zoster treatments: results of a clinical trial relative to the use of rifamycin sv versus neuramide
title_unstemmed Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
topic Biochemistry (medical), Cell Biology, Biochemistry, General Medicine
url http://dx.doi.org/10.1177/030006058401200406